The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial

✍ Scribed by Patricia J.M. Best; Steven R. Steinhubl; Peter B. Berger; Arijit Dasgupta; Danielle M. Brennan; Lynda A. Szczech; Robert M. Califf; Eric J. Topol

• Book ID: 116191243
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 231 KB
• Volume: 155
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2007.10.046